NCT03793283View on ClinicalTrials.gov

Continuous Subcutaneous Insulin Infusion Versus Multiple Dose Insulin Injections in Routine Clinical Practice

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

CSII

Currently receiving CSII therapy during 6 or more months.

DRUG

Multiple dose insulin injections

Currently receiving MDI therapy during 6 or more months.

Trial Locations (1)

13005

Obispo Rafael Torija, St., Ciudad Real

All Listed Sponsors
collaborator

University of Castilla-La Mancha

OTHER

collaborator

Universidad de Córdoba

OTHER

lead

Castilla-La Mancha Health Service

OTHER

NCT03793283 - Continuous Subcutaneous Insulin Infusion Versus Multiple Dose Insulin Injections in Routine Clinical Practice | Biotech Hunter | Biotech Hunter